Early Access — free while we kick the tires
EdgarHawk

Richard F Pops

Director

Director

Latest: Director selling · May 2026

1 filing analyzed · 1 company · Latest 2026-05-18

Companies

Company Buys Sells Direction
NEUROCRINE BIOSCIENCES INC NBIX 0 2 Net selling

Activity

May 2026
low
Sell
15,000 shares
$2,364,760
Significance 4/10

Director Richard Pops sold 15,000 NBIX shares at $157.65 for $2.4M via pre-arranged 10b5-1 plan on 2026-05-15.

Richard F Pops sold 15,000 shares (30.3% of his pre-transaction holdings of 49.5K shares) at $157.65, leaving him with 34.5K shares post-transaction. This sale was executed under a pre-arranged 10b5-1 trading plan, meaning it was scheduled rather than discretionary. The company's fundamentals remain solid with revenue of $814.5M (annual growth +21.4%) and net income of $197.9M, supporting a current valuation of $15.8B market cap at a P/E of 23.64. The stock has appreciated 18.0% over the past 30 days and 23.0% over 90 days, trading at $157.21 currently, near its 52-week high of $162.39. As a scheduled transaction under a 10b5-1 plan, this sale carries no timing signal and should be evaluated solely as a change in the director's residual position from 49.5K to 34.5K shares.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access